U.S. Business Day Squawk Box
Call it crowd-sourcing for algorithmic trading.
Mylan's decision to "gouge" consumers on lifesaving EpiPen devices is corporate "greed on steroids," consumer advocate Ralph Nader tells CNBC.
But Dallas Fed President Robert Kaplan refuses to put a timetable on a possible hike.
Pharmaceutical company Mylan has reduced the cost of EpiPens for some people — but at the end of the day, its CEO told CNBC she has a business to run.
Shares of Mylan held slightly lower in afternoon trade, giving up earlier gains of more than 4 percent.
Mylan announced plans to boost access to its EpiPen Auto-Injector by expanding programs for patients who are facing higher out-of-pocket costs.
Mylan CEO Heather Bresch speaks to CNBC on Thursday about the controversy surrounding her company's 400-percent price hike to EpiPens over the past few years.
Price increases on life-saving EpiPens have parents outraged — but the CEO of the company that makes them said no one's more frustrated than her.
Heather Bresch, Mylan CEO, says lawmakers have not called her back after she reached out to members of Congress. We are doing everything we can to ensure no one goes without an EpiPen, says Bresch.
Jim Cramer is keeping an eye on shares of Mylan after CEO Heather Bresch's CNBC interview where she addressed criticism surrounding the cost of the EpiPen and her frustration with Congress.
Heather Bresch, Mylan CEO, says the fight is on to fix the health care system and she is willing to work with Congress to make it happen.
Heather Bresch, Mylan CEO, says the health care system is broken and if you don't play in the system your products won't get to patients.
Heather Bresch, Mylan CEO, urges changes to update the U.S. health care system and talks about the need to bring down drug costs. Patients are paying twice, says Bresch.
Heather Bresch, Mylan CEO, discusses the need to update the U.S. health care system, and the company's plan to provide an alternate route on pricing.
Heather Bresch, Mylan CEO talks about her frustration with the rising price of drugs.
Heather Bresch, Mylan CEO breaks down the pricing path of the EpiPen and the company's plan to expand access to the drug.
Heather Bresch, Mylan CEO, responds to the controversy surround the company's 400-percent increase for its injectable allergy medicine.
In a wide-ranging interview, Heather Bresch, Mylan CEO sits CNBC's Brian Sullivan to discuss the controversy surround the recent 400-percent increase in the EpiPen and her frustration with the health care system.
CNBC's Rick Santelli breaks down the latest numbers on unemployment and durable goods.
Susan Lyne, BBG Ventures president & founder, talks about encouraging more women to enter the field of technology and focus on start-ups and venture capital.
About Squawk Box
- "Squawk Box" is the ultimate "pre-market" morning news and talk program, where the biggest names in business and politics tell their most important stories. Anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin, the show brings Wall Street to Main Street. It's a "must see" for everyone from the professional trader to the casual investor.
Contact Squawk Box
-
CNBC NEWSLETTERS
Get the best of CNBC in your inbox
Get these newsletters delivered to your inbox, and more info about about our products and service. Privacy Policy.▲Showtimes
U.S.
Weekdays 6a ETEMEA
Weekdays 13:00 CETAsia
Weekdays 18:00 SIN/HKAustralia
Weekdays 20:00 SYDBecky Quick is co-anchor of "Squawk Box" and also anchor of the nationally syndicated "On the Money."
Andrew Ross Sorkin is a co-anchor of "Squawk Box," a financial columnist for "The New York Times" and the editor-at-large of NYT's DealBook.
